Yarosh, Rina A.
Nichols, Hazel B.
Hirschey, Rachel
Kent, Erin E.
Mayer, Deborah K.
Troester, Melissa A.
Butler, Eboneé N.
Funding for this research was provided by:
Susan G Komen Foundation (TREND21686258, SAC210102)
National Institute of Minority Health and Disparities (K23 Md015719-01)
University Cancer Research Fund of North Carolina (OGUNC1202)
National Cancer Institute (R01CA253450)
National Cancer Institute Specialized Program of Research Excellence (SPORE) in Breast Cancer (NIH/NCI P50-CA058223)
U.S. Department of Justice (HT94252310235)
Article History
Received: 19 September 2024
Accepted: 25 February 2025
First Online: 7 March 2025
Declarations
:
: The authors declare no competing interests.
: The study was approved by the University of North Carolina Institutional Review Board in accordance with U.S. Common Rule. All study participants provided written informed consent prior to study entry. This study complied with relevant ethical regulations, including the Declaration of Helsinki.
: Informed consent was obtained from all individual participants included in the Carolina Breast Cancer Study.
: NA as this study does not present any one individual’s data.